Evkeeza is a first-in-class medicine approved by the U.S. Food and Drug Administration (FDA) and European Commission (EC) to treat an ultra-rare inherited form of high cholesterol
PR Newswire
TARRYTOWN, N.Y. and NOVATO, Calif., Jan. 7, 2022
PR Newswire
TARRYTOWN, N.Y. and NOVATO, Calif., Jan. 7, 2022
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey